PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) is a publicly traded company in the Unknown sector. Across all available filings, 22 corporate insiders have executed 1000 transactions totaling $70.9M, demonstrating a bearish sentiment with -$70.9M in net insider flow. The most recent transaction on Dec 5, 2011 involved a transaction of 21,479 shares valued at $714.2K.
No significant insider buying has been recorded for PPDI in the recent period.
No significant insider selling has been recorded for PPDI in the recent period.
Based on recent SEC filings, insider sentiment for PPDI is bearish with an Insider Alignment Score of 0/100 and a net flow of -$70.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 22 insiders are actively trading PPDI stock, having executed 1000 transactions in the past 90 days. The most active insider is Fredric N. Eshelman (Executive), who has made 447 transactions totaling $270.2M.
Get notified when executives and directors at PPDI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 5, 2011 | Bondurant Stuart | Executive | Disposition | 21,479 | $33.25 | $714.2K | Large |
| Dec 5, 2011 | Colvin Paul | Executive | Disposition | 45 | $33.25 | $1.5K | |
| Dec 5, 2011 | G. Darazsdi Daniel | Executive | Disposition | 13,195 | $33.25 | $438.7K | |
| Dec 5, 2011 | N. Eshelman Fredric | Executive | Disposition | 1,685 | $33.25 | $56.0K | |
| Dec 5, 2011 | N. Eshelman Fredric | Executive | Disposition | 6,984,741 | $33.25 | $232.2M | Large |
| Dec 5, 2011 | N. Eshelman Fredric | Executive | Disposition | 394,500 | $33.25 | $13.1M | Large |
| Dec 5, 2011 | N. Eshelman Fredric | Executive | Disposition | 11,258 | $33.25 | $374.3K | |
| Dec 5, 2011 | Frank Fred | Executive | Disposition | 72,565 | $33.25 | $2.4M | Large |
| Dec 5, 2011 | Alexander Ingram Robert | Executive | Disposition | 1,139 | $33.25 | $37.9K | |
| Dec 5, 2011 | O. Wilkinson Michael | Executive | Disposition | 2,362 | $33.25 | $78.5K | |
| Dec 5, 2011 | Magnuson Terry | Executive | Disposition | 17,633 | $33.25 | $586.3K | Large |
| Dec 5, 2011 | Mario Ernest | Executive | Disposition | 58,244 | $33.25 | $1.9M | Large |
| Dec 5, 2011 | Mario Ernest | Executive | Disposition | 6,000 | $33.25 | $199.5K | |
| Dec 5, 2011 | Mario Ernest | Executive | Disposition | 6,000 | $33.25 | $199.5K | |
| Dec 5, 2011 | Mario Ernest | Executive | Disposition | 193,069 | $33.25 | $6.4M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Disposition(D) | 21 | $266.5M | 75.9% |
Sale(S) | 781 | $70.9M | 20.2% |
Exercise(M) | 47 | $13.0M | 3.7% |
Discretionary(I) | 43 | $311.9K | 0.1% |
Payment(F) | 1 | $207.6K | 0.1% |
Award(A) | 40 | $0 | 0.0% |
Gift(G) | 37 | $0 | 0.0% |
Other(J) | 30 | $0 | 0.0% |
Insider selling pressure at PHARMACEUTICAL PRODUCT DEVELOPMENT INC has increased, with 22 insiders executing 1000 transactions across all time. Total sales of $70.9M significantly outpace purchases of $0, resulting in a net outflow of $70.9M. This selling activity appears largely discretionary, which may warrant closer attention from investors.